53fb5f38-b55a-46eb-b90b-d77951370687-PIN

Emerging risk Identification through analysis of botanical substances in food supplements

Status
open for submission
Estimated value
€200,000
Published
16 Apr 2026
Submission
Electronic submission
Tender summary

The contract aims to support EFSA’s emerging risk identification by prioritising and analysing the composition of food supplements made of plants reported to contain substances with QSAR-predicted carcinogenic, mutagenic or reprotoxic properties. The listed estimated value is €200,000.

What the buyer needs

  • The contract aims to support EFSA’s emerging risk identification by prioritising and analysing the composition of food supplements made of plants reported to contain substances with QSAR-predicted carcinogenic, mutagenic…
  • The work will build on existing EFSA and Member State activities and help EFSA and Member Stated competent authorities to decide how to follow-up on this issue.

Procurement signals

  • Procedure: EFSA/2026/OP/0006-PIN
  • Procedure type: Source procedure code 47396222
  • Contract type: Services contract (31095498)
  • Submission method: Electronic submission
  • Published: 16 Apr 2026

Procurement categories

CPV 73000000

CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.

Programme and geography

Programme period 2014 - 2020Programme period 2021 - 2027

Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.

Source-backed details

Original identifiers and classification fields from the EU tender source.

Procedure identifier
EFSA/2026/OP/0006-PIN
Business identifier
53fb5f38-b55a-46eb-b90b-d77951370687-PIN
Procedure type
Source procedure code 47396222
Contract type
Services contract (31095498)
Authority source ID
47352394
Tender timezone
Europe/Rome
Fetched
15 Jul 2026, 07:21 UTC
Full official description

The contract aims to support EFSA’s emerging risk identification by prioritising and analysing the composition of food supplements made of plants reported to contain substances with QSAR-predicted carcinogenic, mutagenic or reprotoxic properties. The work will build on existing EFSA and Member State activities and help EFSA and Member Stated competent authorities to decide how to follow-up on this issue.